| TC | Stat | Stk | Ins | Fil | +d | +w | +m | +q | +h | +y | avg | 
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 6 | 1 | 1 | 0 | -8 | -3 | -15 | -4 | 
| S | %wins | 67 | 33 | 67 | 67 | 33 | 67 | 56 | 
| Filing Date | T Date | Ticker | Issuer | Inc | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/3/16 17:24 | 2/1/16 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Guerdan Melissa | MA | O | SVP,Glob | S.d | -135 | 54.00 | 33 | -3 | -100 | 0 | D | 42 | 32 | 8 | 17 | 41 | 40 | 39 | 48 | 0 | -1 | 0 | -25 | -32 | -30 | 
| 9/4/15 16:01 | 9/3/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Guerdan Melissa | MA | O | SVP,Glob | S | -267 | 52.00 | 33 | -5 | -100 | 0 | D | 63 | 45 | 13 | 1 | 2 | -5 | 3 | 0 | 3 | 3 | -1 | -20 | 5 | -23 | 
| 9/2/15 16:51 | 9/1/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Guerdan Melissa | MA | O | SVP,Glob | S.d | -252 | 50.48 | 33 | -5 | -49 | 5 | D | 64 | 41 | 11 | -2 | -2 | -5 | -4 | -3 | 0 | 1 | -4 | -20 | 4 | -25 | 
| 5/4/15 16:58 | 4/30/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Guerdan Melissa | MA | O | SVP,Glob | S.d | -145 | 47.81 | 17 | -3 | -100 | 0 | D | 88 | 43 | 26 | 19 | 0 | -3 | -3 | 0 | 1 | 2 | 5 | 0 | -5 | -17 | 
| 4/8/15 19:53 | 4/6/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Guerdan Melissa | MA | O | SVP,Glob | S.d | -125 | 50.00 | 32 | -3 | -100 | 0 | D | 96 | 43 | 26 | 36 | 11 | 3 | 7 | 3 | 0 | -1 | -4 | 5 | 1 | 1 | 
| 3/25/15 16:38 | 3/23/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Guerdan Melissa | MA | O | SVP,Glob | S.d | -651 | 48.35 | 32 | -13 | -100 | 0 | D | 98 | 33 | 20 | 24 | 12 | 3 | -3 | -1 | -1 | 4 | 6 | 10 | 10 | 7 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |